(Q46560452)

English

Side effects of combined therapy of methylprednisolone and intravenous immunoglobulin in Guillain-Barré syndrome

scientific article published on 20 June 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15970631

Side effects of combined therapy of methylprednisolone and intravenous immunoglobulin in Guillain-Barré syndrome (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15970631

Guillain–Barré syndrome

0 references

methylprednisolone

1 reference

based on heuristic

inferred from title

5

object named as

Yuki N

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15970631

author name string

Odaka M

1

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15970631

Tatsumoto M

2

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15970631

Hoshiyama E

3

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15970631

Hirata K

4

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15970631

publication date

20 June 2005

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15970631

European Neurology

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15970631

53

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15970631

4

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15970631

194-196

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15970631

Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barré syndrome: randomised trial

1 reference

https://api.crossref.org/works/10.1159%2F000086477

21 January 2018

Corticosteroids for prevention of adverse reactions to intravenous immune serum globulin infusions in hypogammaglobulinemic patients

1 reference

https://api.crossref.org/works/10.1159%2F000086477

21 January 2018

Assessment of current diagnostic criteria for Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1159%2F000086477

21 January 2018

Side effects of intravenous immunoglobulins in neurological autoimmune disorders--a prospective study

1 reference

https://api.crossref.org/works/10.1159%2F000086477

21 January 2018

Aseptic meningitis associated with high-dose intravenous immunoglobulin therapy: frequency and risk factors

1 reference

https://api.crossref.org/works/10.1159%2F000086477

21 January 2018

Complications of intravenous immune globulin treatment in neurologic disease

1 reference

https://api.crossref.org/works/10.1159%2F000086477

21 January 2018

Identifiers

10.1159/000086477

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15970631

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15970631

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46560452&oldid=2118180784"